Sequence Design
Therapeutic ASOs are designed in silico to target mRNA sequences of interest with optimal binding while minimizing off-target effects. Streamline sequence design and predict the best candidates for development and bioprocessing with Genedata Biopharma Platform. Insourced sequence synthesis information can be uploaded to IDBS Polar Biopharma Lifecycle Management software for easy data management and tracking across sites. Outsourcing oligonucleotide synthesis to IDT provides increased quality and scale that align with development or manufacturing needs.